According to Puma Biotechnology's latest financial reports and stock price the company's current Operating Margin is 2.28%. At the end of 2022 the company had an Operating Margin of 0.22%.
Year | Operating Margin | Change |
---|---|---|
2022 | 0.22% | -101.93% |
2021 | -11.37% | -57.18% |
2020 | -26.57% | -4.31% |
2019 | -27.76% | -38.66% |
2018 | -45.26% | -95.71% |
2017 | -1,054.15% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.